Related Experiment Videos
[Semiautomatic insulin injection equipment (pens)].
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|October 9, 1990
Summary
Achieving good glycaemic control is vital for preventing diabetes complications, but requires careful management to avoid hypoglycemia. The basal-bolus insulin concept, often using pens, offers a viable option for select patients, emphasizing individualized therapy.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacotherapy
Context:
- Diabetes mellitus management necessitates stringent glycaemic control to mitigate long-term degenerative complications.
- The basal-bolus insulin regimen is a recognized strategy for achieving optimal blood glucose levels.
- Insulin delivery devices, such as pens, enhance patient adherence to complex therapeutic regimens.
Purpose:
- To evaluate the efficacy and applicability of the basal-bolus insulin concept in diabetes management.
- To discuss the role of insulin pens in improving patient compliance with intensive insulin therapy.
- To highlight the importance of individualized treatment strategies in diabetes care.
Summary:
- Good glycaemic control is essential for preventing or delaying diabetic complications, though it carries an increased risk of hypoglycemia.
- The basal-bolus insulin regimen, facilitated by insulin pens, can improve control but requires patient education and cooperation.
- This intensive therapy is not universally suitable, particularly for elderly diabetic patients, and requires individualized assessment.
- Misconceptions exist regarding the universal application of insulin pens and multiple daily injections for all type 1 diabetics.
Impact:
- Emphasizes the need for personalized diabetes treatment plans over generalized recommendations.
- Highlights that insulin pens and basal-bolus therapy are tools, not universal solutions, for diabetes control.
- Underscores the importance of comprehensive diabetes care, including foot care and blood pressure monitoring, alongside glycaemic management.